Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

A Link between Serotonin-… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety.

Artikel i vetenskaplig tidskrift
Författare Furmark
Appel
Susanne Henningsson
Ahs
Faria
Linnman
Pissiota
Frans
Bani
Bettica
Pich
Jacobsson
Wahlstedt
Oreland
L?ngstr?m
Elias Eriksson
Fredrikson
Publicerad i The Journal of neuroscience : the official journal of the Society for Neuroscience
Volym 28
Nummer/häfte 49
Sidor 13066-13074
ISSN 1529-2401
Publiceringsår 2008
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi
Sidor 13066-13074
Språk en
Länkar dx.doi.org/10.1523/JNEUROSCI.2534-0...
Ämnesord Serotonin-related gene, amygdala activity, social anxiety
Ämneskategorier Farmakologi och toxikologi

Sammanfattning

Placebo may yield beneficial effects that are indistinguishable from those of active medication, but the factors underlying proneness to respond to placebo are widely unknown. Here, we used functional neuroimaging to examine neural correlates of anxiety reduction resulting from sustained placebo treatment under randomized double-blind conditions, in patients with social anxiety disorder. Brain activity was assessed during a stressful public speaking task by means of positron emission tomography before and after an 8 week treatment period. Patients were genotyped with respect to the serotonin transporter-linked polymorphic region (5-HTTLPR) and the G-703T polymorphism in the tryptophan hydroxylase-2 (TPH2) gene promoter. Results showed that placebo response was accompanied by reduced stress-related activity in the amygdala, a brain region crucial for emotional processing. However, attenuated amygdala activity was demonstrable only in subjects who were homozygous for the long allele of the 5-HTTLPR or the G variant of the TPH2 G-703T polymorphism, and not in carriers of short or T alleles. Moreover, the TPH2 polymorphism was a significant predictor of clinical placebo response, homozygosity for the G allele being associated with greater improvement in anxiety symptoms. Path analysis supported that the genetic effect on symptomatic improvement with placebo is mediated by its effect on amygdala activity. Hence, our study shows, for the first time, evidence of a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced anxiety relief.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?